Lombard Odier Asset Management (USA)’s Bristol-Myers Squibb BMY Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.3M	Sell	450,000 -25,000	-5%	-$1.46M	2.85%	8
2025 Q4	$25.6M	Hold	475,000	–	–	2.38%	10
2025 Q3	$21.4M	Hold	475,000	–	–	1.44%	14
2025 Q2	$22M	Hold	475,000	–	–	1.67%	13
2025 Q1	$29M	Hold	475,000	–	–	2.28%	9
2024 Q4	$26.9M	Buy	475,000 +75,000	+19%	+$4.19M	1.98%	11
2024 Q3	$20.7M	Sell	400,000 -50,000	-11%	-$2.35M	1.38%	17
2024 Q2	$18.7M	Buy	450,000 +300,000	+200%	+$13.4M	1.38%	23
2024 Q1	$8.13M	Buy	+150,000	New	+$7.64M	0.2%	92
2022 Q1	–	Sell	-45,000	Closed	-$2.81M	–	337
2021 Q4	$2.81M	Sell	45,000 -22,500	-33%	-$1.32M	0.11%	100
2021 Q3	$3.99M	Buy	+67,500	New	+$4.45M	0.17%	79
2019 Q2	–	Sell	-98,000	Closed	-$4.68M	–	235
2019 Q1	$4.68M	Buy	+98,000	New	+$4.88M	0.38%	71

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s BMY Position: Q1 2022 in Review

Lombard Odier Asset Management (USA) sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 60,000 shares — an estimated $3.74M sold.

Lombard Odier Asset Management (USA) first reported a position in BMY in Q2 2013 and held it in 7 quarters. The position peaked at $22.1M in Q1 2014. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Lombard Odier Asset Management (USA) reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 60,000 Bristol-Myers Squibb shares in Q1 2022, an estimated $3.74M.
Lombard Odier Asset Management (USA) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 7 quarters.
Lombard Odier Asset Management (USA)'s Bristol-Myers Squibb position peaked at $22.1M in Q1 2014.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2022, filed 16 May 2022.